Markus G Manz

This inventor holds 28 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 18 EPO patents, primarily in Genetically Modified Animals. Top assignees: Regeneron Pharmaceuticals, Inc., Yale University, Institute for Research in Biomedicine. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Markus G Manz. Retrieved from https://idiyas.com/inventor/markus-g-manz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 18 (Patent Applications = 15)

Average Co-Inventor Count = 7.6

ph-index = 10

Forward Citations = 224(Granted Patents)

Location History:

Zurich, CH (2013 - 2017)
Zollikon, CH (2014 - 2023)
Bellinzona, CH (2019 - 2023)

Company Filing History:

24 out of 1,479

Regeneron Pharmaceuticals, Inc.

Institute for Research in Biomedicine

patents

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Genetically Modified Animals

Humanized Mice

Engraftment Techniques

Transgenic Mice

EPO Expression

M-CSF Mice

Animal Models

Methods of Use

Human SIRPα

Non-Human Animals

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12696884 - GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO (2026-08-04),

2. 12672643 - GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF (2026-07-07),

3. 12402611 - Genetically modified mice and engraftment (2025-09-02),

4. 12127537 - Genetically modified non-human animals and methods of use thereof (2024-10-29),

5. 12127536 - Humanized M-CSF mice (2024-10-29),

6. 11778995 - Genetically modified non-human animals and methods of use thereof (2023-10-10),

7. 11766032 - Genetically modified non-human animals expressing human EPO (2023-09-26),

8. 11576356 - Genetically modified non-human animals and methods of use thereof (2023-02-14),

9. 11051499 - Genetically modified mice and engraftment (2021-07-06),

10. 11026408 - Genetically modified non-human animals and methods of use thereof (2021-06-08),

11. 10785968 - Genetically modified non-human animals and methods of use thereof (2020-09-29),

12. 10785966 - Humanized M-CSF mice (2020-09-29),

13. 10561126 - Genetically modified non-human animals and methods of use thereof (2020-02-18),

14. 10463028 - Genetically modified non-human animals expressing human EPO (2019-11-05),

15. 10433527 - Genetically modified non-human animals and methods of use thereof (2019-10-08),

Title: Markus G Manz - Innovative Inventor from Zollikon

Introduction: Markus G Manz is a renowned inventor hailing from Zollikon, Switzerland. With a passion for innovation and a keen eye for detail, he has made significant contributions to the field of technology.

Latest Patents: Markus G Manz holds several patents in the areas of electronics, robotics, and sustainable energy solutions. His recent patents focus on enhancing efficiency in manufacturing processes and improving renewable energy technologies.

Career Highlights: Throughout his career, Markus G Manz has worked with leading tech companies to develop cutting-edge solutions. His expertise in product development and problem-solving has led to the successful implementation of various inventions in the market.

Collaborations: Markus G Manz has collaborated with top researchers, engineers, and designers to bring his ideas to life. His collaborative efforts have resulted in groundbreaking innovations that have revolutionized the industry.

Conclusion: Markus G Manz's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions continue to inspire the next generation of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.